secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001193125-25-317642
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics prices $60M public offering of 50M units at $1.20/unit; warrants at $1.50
--------------------------------------------------------------------------------

- Gross proceeds ~$60M from 50M units, each unit = 1 share + 1 warrant (5-yr, $1.50 exercise).
- Underwriters: Leerink Partners, Piper Sandler, LifeSci Capital. Closing expected Dec 15, 2025.
- Proceeds to fund development of TN-201 and TN-401 and for working capital and general purposes.
- Warrant coverage at 100%; shares and warrants immediately separable on issuance.
- 60-day lockup for officers, directors, and certain stockholders unless consent is given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312525317642/0001193125-25-317642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312525317642/d67398d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-317642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer